newsfilter
← Latest News
GlobeNewswire·

Tiziana Life Sciences Plans to Spinout IL-6 Asset into Separate Listed Company

BOSTON, Dec. 02, 2025 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) ("Tiziana" or the "Company"), a biotechnology company developing breakthrough immunomodulation therapies, today announced that it